News

Your contact person

Manager PR & Communications Jan Phillip Denkers

Image: ©Eppendorf AG

Eppendorf Award 2022: Call for Entries

The Eppendorf Award for Young European Investigators, endowed with 20,000 EUR, is granted annually to an early career scientist in Europe for outstanding contributions to ...

Read more …
The facility employs J.POD® technology that uses autonomous clean rooms to run small, highly intensified production processes, thereby reducing the cost of biologics manufacturing. (Picture: ©Benjamin Benschneider)

Just - Evotec Biologics opens J.POD® 1 US

Evotec SE announced the opening of the company’s late-stage clinical and commercial biologics cGMP manufacturing facility (J.POD® 1 US) in Redmond, Washington. ...

Read more …
Funds to be used to obtain clinical proof of concept in two programs and to accelerate innovative pipeline focused on restoring immune tolerance to treat and potentially cure autoimmune diseases (Picture: ©Topas Therapeutics)

Topas Therapeutics Extends Series B

Topas Therapeutics GmbH (Topas), a private biotechnology company developing immune tolerance-inducing drugs to treat and potentially cure a variety of autoimmune diseases, today ...

Read more …
Evotec creates further opportunities for long-term growth with "Campus Levi-Montalcini" in Verona. (Picture: ©Z S / Unsplash)

Evotec creates long-term growth opportunities

Evotec SE announced that Evotec has added significant opportunities for further, long-term growth by acquiring the Verona site from GlaxoSmithKline SpA (“GSK”). ...

Read more …
Fraunhofer ITMP uses high-tech methods for cell-based drug screening. (Picture: ©Fraunhofer ITMP)

Stem Cell-Based Translation

The North as a hub for global stem cell research: The 2021 Annual Meeting of the International Society for Stem Cell Research (ISSCR) was scheduled ...

Read more …
Dr. Tanmay Bharat, Sir William Dunn School of Pathology, University of Oxford (Picture: ©Eppendorf AG)

Eppendorf Award for Young European Investigators 2021

In 2021, Eppendorf AG, the Hamburg life sciences company, is presenting its highly prestigious research prize for the 26th time. The independent ...

Read more …
Indivumed is using nRavel™ for target discovery and drug development programs. (Picture: ©Jackie Niam/stock.adobe.com)

Indivumed Launches the nRavel AI Platform

Indivumed GmbH (“Indivumed”) today announced the launch of nRavel™, a unique AI discovery platform for oncology and precision medicine. The platform combines ...

Read more …
New Entity to Develop Therapeutics Targeting RAS Pathway Mutations in Colorectal Cancer (Picture: © Indivumed GmbH)

Indivumed Joins KHR Biotech

Indivumed GmbH (“Indivumed”) CEO Dr. Hartmut Juhl and University Medical Center Mainz Professor Krishnaraj Rajalingam today announced Indivumed will be joining the newly formed KHR ...

Read more …
Richter-Helm BioLogics Groundbreaking Management © Richter-Helm BioLogics GmbH & Co. KG

German CDMO Richter-Helm Triples cGMP Production

a leading Germany-based, cGMP compliant biopharmaceutical Contract Development and Manufacturing Organization (CDMO) announced today the start of construction for an expansion project at its cGMP ...

Read more …

Evotec SE reports results for the first quarter 2021

Evotec SE today announced the financial results and corporate updates for the first quarter 2021. ...

Read more …

osteolabs GmbH establishes UK presence

osteolabs GmbH today announces the formation of osteolabs UK Limited in Marlow near London. osteolabs UK is a Joint

Read more …

Sysmex ranks among Germany’s Top 100 employers

Great Place to Work® is an inter­national research and consulting institute that supports companies in around 60 countries in developing their corporate and workplace culture. ...

Read more …